AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Evaluating Clinical Trial Limitations and Outcomes
This chapter delves into the shortcomings of a recent clinical trial on a medical procedure, focusing on the high event rates in patients and the implications of the trial being unblinded. The speakers also explore the potential role of SGLT2 inhibitors in mitigating adverse events and advocate for improved comparative studies in future research.